Star Tribune

Learn with Biosimilar Basics. Part 1 starts with an overview of biosimilar products, sharing what biosimilar drugs are and the difference vs generic drugs.

Shortages in the manufacturing chain have led to label hopping and an increase in off-label use

In the latest episode of the “Pharmacy Friends” podcast, hear about a new clinical report from Prime Therapeutics that dives into the latest evidence-based insights related to the rising prevalence...

publications Cell & Gene Pipeline Outlook: November 2025 Tracking the therapies shaping tomorrow’s care November 12, 2025 Editor-in-chief's message Welcome to Prime Therapeutics’ (Prime) inaugural...

The American Journal of Managed Care (AJMC): The growing list of insurers dropping coverage for costly GLP-1 weight loss drugs leaves patients to bear even higher out-of-pocket expenses while still...

CNN: At 37:03, listen to fitness expert Jillian Michaels cite Prime/Magellan Rx research on a podcast recording of a June 21 CNN broadcast

Maryam Tabatabai, PharmD, associate vice president of clinical information, shares more about how cell and gene therapies are transforming the treatment landscape, and how payers and providers can...

Research on GLP-1 drugs, specialty therapies and more helps improve affordability in health care

PUBLICATIONS FDA Decisions Expected: August 2025 Your monthly synopsis of new drugs expected to hit the market July 16, 2025 Drug pipeline for August 2025 At Prime Therapeutics (Prime), we have...